FIA
FBIO icon

FNY Investment Advisers’s Fortress Biotech FBIO Stock Holding History

FNY Investment Advisers’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,667
Closed -$469K – 525
2020
Q2 		$469K Hold
11,667
– – 0.27% 87
2020
Q1 		$330K Sell
11,667
-1,666
-12% -$55.3K 0.25% 84
2019
Q4 		$514K Hold
13,333
– – 0.16% 96
2019
Q3 		$282K Buy
13,333
+4,349
+48% +$102K 0.09% 131
2019
Q2 		$202K Buy
+8,984
New +$231K 0.06% 155

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FNY Investment Advisers's FBIO Position: Q3 2020 in Review

FNY Investment Advisers sold out of Fortress Biotech (FBIO) in Q3 2020, closing a stake of 11,667 shares — an estimated $469K sold.

FNY Investment Advisers first reported a position in FBIO in Q2 2019 and held it in 5 quarters. The position peaked at $514K in Q4 2019. 77 funds tracked by Wall St. Rank hold FBIO as of Q3 2020.

  • FNY Investment Advisers reported no remaining Fortress Biotech position as of Q3 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 11,667 Fortress Biotech shares in Q3 2020, an estimated $469K.
  • FNY Investment Advisers first reported a position in Fortress Biotech in Q2 2019 and held it in 5 quarters.
  • FNY Investment Advisers's Fortress Biotech position peaked at $514K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2020.

Based on FNY Investment Advisers's 13F filing for Q3 2020, filed 9 Oct 2020.